132 related articles for article (PubMed ID: 26481088)
1. A Pilot Study on the Utility of Serum Metabolomics in Neuroblastoma Patients and Xenograft Models.
Beaudry P; Campbell M; Dang NH; Wen J; Blote K; Weljie AM
Pediatr Blood Cancer; 2016 Feb; 63(2):214-20. PubMed ID: 26481088
[TBL] [Abstract][Full Text] [Related]
2. Serum protein profiling to identify high-risk neuroblastoma: preclinical relevance of blood-based biomarkers.
Sandoval JA; Turner KE; Hoelz DJ; Rescorla FJ; Hickey RJ; Malkas LH
J Surg Res; 2007 Oct; 142(2):268-74. PubMed ID: 17727886
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis of non-tumor cells contributes to increased serum cytochrome c level in a neuroblastoma xenograft model.
Zhang D; Yu JK; Yang FQ; Wang L; Zhang GF; Meng QL; Mu X; Ma W; Jia ZK; Wang JX
Chin Med J (Engl); 2012 Jan; 125(2):316-20. PubMed ID: 22340566
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic profiling in neuroblastoma.
Quintás G; Yáñez Y; Gargallo P; Juan Ribelles A; Cañete A; Castel V; Segura V
Pediatr Blood Cancer; 2020 Mar; 67(3):e28113. PubMed ID: 31802629
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a neuroblastoma mouse model by subcutaneous xenograft transplantation and its use to study metastatic neuroblastoma.
Gao Q; Chen CF; Dong Q; Hou L; Chen X; Zhi YL; Li X; Lu HT; Zhang HY
Genet Mol Res; 2015 Dec; 14(4):16297-307. PubMed ID: 26662423
[TBL] [Abstract][Full Text] [Related]
6. Description of a new xenograft model of metastatic neuroblastoma using NOD/SCID/Il2rg null (NSG) mice.
Sartelet H; Durrieu L; Fontaine F; Nyalendo C; Haddad E
In Vivo; 2012; 26(1):19-29. PubMed ID: 22210712
[TBL] [Abstract][Full Text] [Related]
7. The anti-VEGF antibody bevacizumab potently reduces the growth rate of high-risk neuroblastoma xenografts.
Segerström L; Fuchs D; Bäckman U; Holmquist K; Christofferson R; Azarbayjani F
Pediatr Res; 2006 Nov; 60(5):576-81. PubMed ID: 16988184
[TBL] [Abstract][Full Text] [Related]
8. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of combination therapy using adeno-associated virus--interferon beta and trichostatin A in vitro and in a murine model of neuroblastoma.
Hamner JB; Sims TL; Cutshaw A; Dickson PV; Rosati S; McGee M; Ng CY; Davidoff AM
J Pediatr Surg; 2008 Jan; 43(1):177-82; discussion 182-3. PubMed ID: 18206478
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic targeting of TLR9 inhibits cell growth and induces apoptosis in neuroblastoma.
Brignole C; Marimpietri D; Di Paolo D; Perri P; Morandi F; Pastorino F; Zorzoli A; Pagnan G; Loi M; Caffa I; Erminio G; Haupt R; Gambini C; Pistoia V; Ponzoni M
Cancer Res; 2010 Dec; 70(23):9816-26. PubMed ID: 20935225
[TBL] [Abstract][Full Text] [Related]
11. Metabolomic pattern of childhood neuroblastoma obtained by ¹H-high-resolution magic angle spinning (HRMAS) NMR spectroscopy.
Imperiale A; Elbayed K; Moussallieh FM; Neuville A; Piotto M; Bellocq JP; Lutz P; Namer IJ
Pediatr Blood Cancer; 2011 Jan; 56(1):24-34. PubMed ID: 20949594
[TBL] [Abstract][Full Text] [Related]
12. A plasma metabolomic signature discloses human breast cancer.
Jové M; Collado R; Quiles JL; Ramírez-Tortosa MC; Sol J; Ruiz-Sanjuan M; Fernandez M; de la Torre Cabrera C; Ramírez-Tortosa C; Granados-Principal S; Sánchez-Rovira P; Pamplona R
Oncotarget; 2017 Mar; 8(12):19522-19533. PubMed ID: 28076849
[TBL] [Abstract][Full Text] [Related]
13. Metabolomic study of the fever model induced by baker's yeast and the antipyretic effects of aspirin in rats using nuclear magnetic resonance and gas chromatography-mass spectrometry.
Zhang F; Wang D; Li X; Li Z; Chao J; Qin X
J Pharm Biomed Anal; 2013; 81-82():168-77. PubMed ID: 23670098
[TBL] [Abstract][Full Text] [Related]
14. Toxicometabolomics of urinary biomarkers for human gastric cancer in a mouse model.
Kim KB; Yang JY; Kwack SJ; Park KL; Kim HS; Ryu DH; Kim YJ; Hwang GS; Lee BM
J Toxicol Environ Health A; 2010; 73(21-22):1420-30. PubMed ID: 20954069
[TBL] [Abstract][Full Text] [Related]
15. Expression of p53, or targeting towards EGFR, enhances the oncolytic potency of conditionally replicative adenovirus against neuroblastoma.
Geoerger B; van Beusechem VW; Opolon P; Morizet J; Laudani L; Lecluse Y; Barrois M; Idema S; Grill J; Gerritsen WR; Vassal G
J Gene Med; 2005 May; 7(5):584-94. PubMed ID: 15651070
[TBL] [Abstract][Full Text] [Related]
16. [Identification and expression of cytochrome C in tumor-bearing mice model with neuroblastoma].
Pang YL; Zhang D; Zhao W; Wang L; Qin P; Fan YX; Zhang JJ; Wang JX
Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(36):2909-12. PubMed ID: 24373407
[TBL] [Abstract][Full Text] [Related]
17. Neuroblastoma detection using serum proteomic profiling: a novel mining technique for cancer?
Sandoval JA; Dobrolecki LE; Huang J; Grosfeld JL; Hickey RJ; Malkas LH
J Pediatr Surg; 2006 Apr; 41(4):639-46; discussion 639-46. PubMed ID: 16567169
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of cytoplasmic melanoma-associated antigen at diagnosis may predict clinical relapse in neuroblastoma patients.
Morandi F; Corrias MV; Levreri I; Scaruffi P; Raffaghello L; Carlini B; Bocca P; Prigione I; Stigliani S; Amoroso L; Ferrone S; Pistoia V
Cancer Immunol Immunother; 2011 Oct; 60(10):1485-95. PubMed ID: 21660451
[TBL] [Abstract][Full Text] [Related]
19. A novel metastatic animal model reflecting the clinical appearance of human neuroblastoma: growth arrest of orthotopic tumors by natural, cytotoxic human immunoglobulin M antibodies.
Engler S; Thiel C; Förster K; David K; Bredehorst R; Juhl H
Cancer Res; 2001 Apr; 61(7):2968-73. PubMed ID: 11306475
[TBL] [Abstract][Full Text] [Related]
20. Metabolomic profiling of tumor-bearing mice.
Wettersten HI; Ganti S; Weiss RH
Methods Enzymol; 2014; 543():275-96. PubMed ID: 24924138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
